Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam Monotherapy in Chinese Adults and Adolescents With Focal Epilepsy
ChiCTR2400093210Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of brivaracetam in Focal Onset Epilepsy, sponsored by Beijing Children's Hospital. Primary endpoint: Epilepsy control efficiency. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
brivaracetam
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on ChiCTR2400093210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093210.